A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma
A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma
Recruiting · NCT07678684 · Registry updated 2026-07-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-07-10 | NCT07678684 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| HighField Biopharmaceuticals Corporation | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Huashan Hospital Affiliated to Fudan University | Shanghai | China | 8 |